Peritoneal Carcinomatosis — Trials

Peritoneal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 42
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: University of California, Irvine
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (18)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05277766	Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer(PIPAC-NAL-IRI)	active not recruiting	Phase 1	45	University Hospital, GhentOTHER	1	Jul 13, 2026	clinicaltrials
NCT05700656	Galunisertib Combined With Capecitabine in Advanced CRC With PM	active not recruiting	Phase 1 / Phase 2	31	The Netherlands Cancer InstituteOTHER	1	Jul 13, 2026